212 related articles for article (PubMed ID: 35429045)
41. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood.
Yan H; Toyota E; Anderson M; Abel TJ; Donner E; Kalia SK; Drake J; Rutka JT; Ibrahim GM
J Neurosurg Pediatr; 2018 Nov; 23(3):274-284. PubMed ID: 30544364
[TBL] [Abstract][Full Text] [Related]
42. Deep brain stimulation for drug-resistant epilepsy.
Li MCH; Cook MJ
Epilepsia; 2018 Feb; 59(2):273-290. PubMed ID: 29218702
[TBL] [Abstract][Full Text] [Related]
43. Early Diagnosis and Treatment of Lennox-Gastaut Syndrome.
Resnick T; Sheth RD
J Child Neurol; 2017 Oct; 32(11):947-955. PubMed ID: 28689466
[TBL] [Abstract][Full Text] [Related]
44. Thalamo-cortical network underlying deep brain stimulation of centromedian thalamic nuclei in intractable epilepsy: a multimodal imaging analysis.
Kim SH; Lim SC; Yang DW; Cho JH; Son BC; Kim J; Hong SB; Shon YM
Neuropsychiatr Dis Treat; 2017; 13():2607-2619. PubMed ID: 29089767
[TBL] [Abstract][Full Text] [Related]
45. The unchanging face of Lennox-Gastaut syndrome in adulthood.
Reyhani A; Özkara Ç
Epilepsy Res; 2021 May; 172():106575. PubMed ID: 33721709
[TBL] [Abstract][Full Text] [Related]
46. Safety and efficacy of cathodal transcranial direct current stimulation in patients with Lennox Gastaut Syndrome: An open-label, prospective, single-center, single-blinded, pilot study.
San-Juan D; Ruiz AG; Arriola AB; Pesqueira GQ; Ruffini G; Trenado C
Seizure; 2022 Aug; 100():44-50. PubMed ID: 35751952
[TBL] [Abstract][Full Text] [Related]
47. Brain regions with abnormal network properties in severe epilepsy of Lennox-Gastaut phenotype: Multivariate analysis of task-free fMRI.
Pedersen M; Curwood EK; Archer JS; Abbott DF; Jackson GD
Epilepsia; 2015 Nov; 56(11):1767-73. PubMed ID: 26333833
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome.
Zhang Y; Wang Y; Zhou Y; Zhang L; Yu L; Zhou S
Epilepsy Res; 2016 Dec; 128():176-180. PubMed ID: 27846468
[TBL] [Abstract][Full Text] [Related]
49. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
[TBL] [Abstract][Full Text] [Related]
50. Electroclinical pattern in the transition from West to Lennox-Gastaut syndrome.
Calvo A; Buompadre MC; Gallo A; Gutiérrez R; Valenzuela GR; Caraballo R
Epilepsy Res; 2020 Nov; 167():106446. PubMed ID: 32854045
[TBL] [Abstract][Full Text] [Related]
51. Comparative connectivity correlates of dystonic and essential tremor deep brain stimulation.
Tsuboi T; Wong JK; Eisinger RS; Okromelidze L; Burns MR; Ramirez-Zamora A; Almeida L; Wagle Shukla A; Foote KD; Okun MS; Grewal SS; Middlebrooks EH
Brain; 2021 Jul; 144(6):1774-1786. PubMed ID: 33889943
[TBL] [Abstract][Full Text] [Related]
52. The efficacy and tolerability of auto-stimulation-VNS in children with Lennox-Gastaut syndrome.
Abdelmoity SA; Abdelmoity AA; Riordan SM; Kaufman C; Le Pichon JB; Abdelmoity A
Seizure; 2021 Mar; 86():168-174. PubMed ID: 33626436
[TBL] [Abstract][Full Text] [Related]
53. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.
Eschbach K; Moss A; Joshi C; Angione K; Smith G; Dempsey A; Juarez-Colunga E; Demarest ST
Epilepsy Res; 2018 Nov; 147():95-101. PubMed ID: 30286391
[TBL] [Abstract][Full Text] [Related]
55. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
56. Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.
Kim HJ; Kim HD; Lee JS; Heo K; Kim DS; Kang HC
Epilepsy Res; 2015 Feb; 110():10-9. PubMed ID: 25616450
[TBL] [Abstract][Full Text] [Related]
57. Lennox-Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures.
Vignoli A; Oggioni G; De Maria G; Peron A; Savini MN; Zambrelli E; Chiesa V; La Briola F; Turner K; Canevini MP
Epilepsy Behav; 2017 Dec; 77():73-78. PubMed ID: 29126048
[TBL] [Abstract][Full Text] [Related]
58. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
Samanta D
Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
[TBL] [Abstract][Full Text] [Related]
59. Multi-institutional evaluation of deep brain stimulation targeting using probabilistic connectivity-based thalamic segmentation.
Pouratian N; Zheng Z; Bari AA; Behnke E; Elias WJ; Desalles AA
J Neurosurg; 2011 Nov; 115(5):995-1004. PubMed ID: 21854118
[TBL] [Abstract][Full Text] [Related]
60. Structural connections of the centromedian nucleus of thalamus and their relevance for neuromodulation in generalized drug-resistant epilepsy: insight from a tractography study.
Remore LG; Rifi Z; Nariai H; Eliashiv DS; Fallah A; Edmonds BD; Matsumoto JH; Salamon N; Tolossa M; Wei W; Locatelli M; Tsolaki EC; Bari AA
Ther Adv Neurol Disord; 2023; 16():17562864231202064. PubMed ID: 37822361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
